Connecting the dots, so you don’t have to, Ashfield Advisory is a vital connection and proud part of the EmerGENE network – the first global, multidisciplinary team focused on guiding transformational cell and gene therapies on the pathway to their patients.
Cell and gene therapy is at the cutting edge of healthcare innovation, promising a new era of treatment that has the potential to transform lives for the better.
To overcome the challenges of getting life-changing discoveries to patients, the world needs innovators and experts to guide therapies throughout the clinical to commercial journey. Only then can their awesome potential be realized for patients and their families.
That’s where EmerGENE comes in as the only global end-to-end partner with the multidisciplinary experience and expertise needed to build the blueprints and provide the execution capabilities for your success.
From Advisory to execution, EmerGENE has the capabilities to unlock the potential of your cell and gene therapy and bring transformational treatments to patients.
Building the foundation of success, our select Advisory experts are a cornerstone of EmerGENE team, offering a comprehensive suite of services molded to your needs:
- Commercial and organizational strategies
- Market access and value
- Commercial team build-out and support
- Disease, platform and launch communications
- Omnichannel stakeholder engagement
- Data, analytics and optimization
- HEOR modeling
EmerGENE supports you with tailored services to guide you and your discovery through every stage – from medical affairs and market access and value to medical information services and patient support programs.
Our experts are connected throughout our journey together perfecting your story for every audience.Discover what EmerGENE can do for you